Kepler Capital Markets cut shares of Arkema (OTCMKTS:ARKAY – Free Report) from a strong-buy rating to a hold rating in a report published on Friday morning,Zacks.com reports.
Other research analysts have also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft cut shares of Arkema from a “buy” rating to a “hold” rating in a report on Monday, November 24th. Barclays lowered Arkema from a “hold” rating to a “strong sell” rating in a research note on Tuesday, November 11th. The Goldman Sachs Group raised Arkema from a “hold” rating to a “buy” rating in a research note on Tuesday, February 10th. Finally, Zacks Research cut Arkema from a “hold” rating to a “strong sell” rating in a research note on Tuesday, January 6th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Arkema presently has a consensus rating of “Reduce”.
View Our Latest Report on ARKAY
Arkema Price Performance
About Arkema
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Further Reading
- Five stocks we like better than Arkema
- 3 Signs You May Want to Switch Financial Advisors
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Unlocked: Elon Musk’s Next Big IPO
- REVEALED: Something Big Happening Behind White House Doors
- The $7.5 Trillion Trump Bombshell No One’s Ready For
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
